This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: China Pharmaceutical University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jinlei Bian: Innovator in Immune Regulation
Introduction
Jinlei Bian is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of immune regulation through his innovative research and patents. His work focuses on developing compounds that can effectively activate innate immune pathways to combat tumor cells.
Latest Patents
Jinlei Bian holds a patent for a benzo[b]selenophene STING regulator, which includes a preparation method and its uses. This invention is designed to serve as an immune regulator, effectively activating an innate immune regulation pathway to kill tumor cells. The structure of the compound is detailed in Formula I. The patent represents a significant advancement in the field of immunotherapy.
Career Highlights
Bian is affiliated with China Pharmaceutical University, where he continues to engage in groundbreaking research. His work has garnered attention for its potential applications in cancer treatment and immune system enhancement. With 1 patent to his name, he is recognized for his contributions to pharmaceutical sciences.
Collaborations
Jinlei Bian collaborates with notable colleagues, including Zhiyu Li and Xi Feng. Their combined expertise fosters a productive research environment that enhances the development of innovative solutions in the pharmaceutical field.
Conclusion
Jinlei Bian's work exemplifies the intersection of innovation and healthcare, particularly in the realm of immune regulation. His contributions are paving the way for new therapeutic approaches to cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile